In a recent study we found that increased expression of the IFN-β-inducible MX1 gene correlated with high expression of the IL10 gene in blood cells, and IL10 gene expression was lower in untreated MS patients with treatment-induced, neutralizing anti-IFN-β antibodies [18]. The gene discussed is IFNB1; the disease is myeloid sarcoma.